CareTrust REIT vs National Health Investors
CTRE and NHI side by side, both in miscellaneous investing. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTRE and NHI compare
CareTrust REIT is the larger company, worth 2.6 times as much as National Health Investors ($8.6B against $3.3B).
On earnings, National Health Investors is cheaper: it trades at 19.4× trailing earnings, against 22.9× for CareTrust REIT.
CareTrust REIT grew revenue faster over the last twelve months (53.0% versus 23.9% for National Health Investors).
CareTrust REIT keeps more of each dollar of sales as profit, with a net margin of 62.2% compared with 38.6% at National Health Investors.
Both pay dividends: CareTrust REIT yields 4.1% and National Health Investors 5.5%.
CareTrust REIT scores higher on the StockData Score (15 against 14 for National Health Investors), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTRE | NHI |
|---|---|---|
| Size and price | ||
| Market cap | $8.6B | $3.3B |
| Share price | $36.39 | $67.04 |
| Change, 1 year | 7.1% | −8.9% |
| Change, 5 years | 72.5% | 20.9% |
| Beta (5Y) | 0.52 | 0.38 |
| Employees | 43 | 32 |
| StockData Score | ||
| Total score | 15 (better) | 14 |
| Valuation score | 2 | 3 (better) |
| Growth score | 4 | 5 (better) |
| Performance score | 4 (better) | 3 |
| Health score | 1 (better) | 0 |
| Dividend score | 4 (better) | 3 |
| Valuation | ||
| P/E | 22.9× | 19.4× (better) |
| P/S | 15.0× | 7.6× (better) |
| P/B | 1.9× (better) | 2.1× |
| EV/EBITDA | 16.2× | – |
| PEG | – | 0.72 |
| Fair value | $32.95 | $69.56 |
| Margin of safety | −10.4% | 3.6% (better) |
| Growth | ||
| Revenue growth (TTM) | 53.0% (better) | 23.9% |
| Revenue growth, 5Y average | 21.7% (better) | 2.5% |
| Net income growth (TTM) | 61.6% (better) | 16.7% |
| EPS growth (TTM) | 32.5% (better) | 10.5% |
| EPS growth, 5Y average | 13.1% (better) | −6.1% |
| Profitability | ||
| Net margin | 62.2% (better) | 38.6% |
| Return on equity | 9.1% | 10.9% (better) |
| Financial health | ||
| Altman Z-score | 3.74 (better) | 2.93 |
| Piotroski F-score | 5 | 5 |
| Dividends and buybacks | ||
| Dividend yield | 4.1% | 5.5% (better) |
| Payout ratio | 85.9% | 105% |
| Years of dividend growth | 11 (better) | 1 |
| Dividend growth, 5Y average | 6.0% (better) | −4.6% |
| Buyback yield | −13.8% | −3.1% (better) |
| Shareholder yield | −9.7% | 2.4% (better) |
| Ownership | ||
| Held by institutions | 106% | 77.7% |
| Held by insiders | 0.99% | 2.5% |
| Insider net buying, 12 months | – | $167K |
| Short interest, % of float | 4.7% | 5.0% |
Go deeper
- CTRE stock overview
- CTRE income statement
- CTRE valuation and score
- NHI stock overview
- NHI income statement
- NHI valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.